Gamida Cell Company

Gamida Cell is a biopharmaceutical company developing advanced cell therapies for patients with blood cancers and hematologic diseases.
Technology:
Cell Therapy, Stem cell therapy
Industry:
Biotechnology, Public
Headquarters:
Jerusalem, Yerushalayim, Israel
Founded Date:
1998-01-01
Employees Number:
101-250
Funding Status:
IPO
Investors Number:
14
Total Funding:
292753823
Estimated Revenue:
$10M to $50M
Last Funding Date:
2022-09-28
Last Funding Type:
Post-IPO Debt
Register and Claim Ownership